Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium

Autor: Özgür M Koc, Bert Aertgeerts, Pavlos Mamouris, Rob Bielen, Dana Busschots, Geert Goderis, Geert Robaeys, Frederik Nevens, Catharina Matheï, Bert Vaes
Přispěvatelé: RS: NUTRIM - R2 - Liver and digestive health, Medische Microbiologie, Promovendi NTM
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
HBsAg
General Practice
medicine.disease_cause
testing policy
0302 clinical medicine
Belgium
general practitioners
Risk Factors
INFECTION
EPIDEMIOLOGY
PLUS SOFOSBUVIR
Registries
030212 general & internal medicine
education.field_of_study
Medical record
PRIMARY-CARE
virus diseases
Viral hepatitis b
General Medicine
Middle Aged
Hepatitis B
Hepatitis C
PREVALENCE
Female
030211 gastroenterology & hepatology
General practice / Family practice
Viral hepatitis
RIBAVIRIN
Life Sciences & Biomedicine
viral hepatitis
Adult
medicine.medical_specialty
Hepatitis C virus
Population
03 medical and health sciences
Medicine
General & Internal
Internal medicine
General & Internal Medicine
medicine
Humans
Serologic Tests
education
Hepatitis B virus
CHRONIC HCV
Hepatitis B Surface Antigens
Community level
Science & Technology
business.industry
Research
Hepatitis C Antibodies
VIRUS GENOTYPE 1
medicine.disease
digestive system diseases
Logistic Models
business
Zdroj: BMJ Open
BMJ Open, 9(5):026464, 1-9. BMJ Publishing Group
ISSN: 2044-6055
Popis: Objectives Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) have a major impact on mortality worldwide. Although effective treatments are available for both HBV and HCV infection
Databáze: OpenAIRE
Externí odkaz: